{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:35:19Z","timestamp":1789994119174,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,30]],"date-time":"2015-09-30T00:00:00Z","timestamp":1443571200000},"content-version":"vor","delay-in-days":333,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CBB","award":["APQ-01670-11"],"award-info":[{"award-number":["APQ-01670-11"]}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["477187\/2010-2"],"award-info":[{"award-number":["477187\/2010-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PRONEX-Dengue","award":["550106\/2010-3"],"award-info":[{"award-number":["550106\/2010-3"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.antiviral.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T16:52:49Z","timestamp":1411145569000},"page":"82-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["MEK\/ERK activation plays a decisive role in yellow fever virus replication: Implication as an antiviral therapeutic target"],"prefix":"10.1016","volume":"111","author":[{"given":"Jonas D.","family":"Albarnaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo C.","family":"De Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice A.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael M.","family":"Palhares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa C.","family":"Casteluber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiney M.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo L.","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ary\u00e1dina M.R.","family":"De Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina C.","family":"Pacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo C.P.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erna G.","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio L.","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio A.","family":"Bonjardim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.09.004_b0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/BJ20031375","article-title":"The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication","volume":"381","author":"Andrade","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.antiviral.2014.09.004_b0010","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.4161\/hv.28117","article-title":"The yellow fever 17D virus as a platform for new live attenuated vaccines","volume":"10","author":"Bonaldo","year":"2014","journal-title":"Hum. Vaccine Immunother."},{"key":"10.1016\/j.antiviral.2014.09.004_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2007.12.007","article-title":"Highly pathogenic RNA viral infections: challenges for antiviral research","volume":"78","author":"Bray","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.09.004_b0020","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.1371\/journal.pntd.0000483","article-title":"Assessment of yellow fever epidemic risk: an original multi-criteria modeling approach","volume":"3","author":"Briand","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2014.09.004_b0030","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/JCM.00842-06","article-title":"Development of multiplex real-time reverse transcriptase PCR assays for detecting eight medically important flaviviruses in mosquitoes","volume":"45","author":"Chao","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2014.09.004_b0035","doi-asserted-by":"crossref","first-page":"10543","DOI":"10.1128\/JVI.78.19.10543-10555.2004","article-title":"Infectious entry of West Nile virus occurs through a clathrin mediated endocytic pathway","volume":"78","author":"Chu","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.09.004_b0040","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bcp.2012.12.011","article-title":"Antivirals: past, present and future","volume":"85","author":"De Clercq","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2014.09.004_b0045","doi-asserted-by":"crossref","first-page":"38353","DOI":"10.1074\/jbc.M100183200","article-title":"A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK\/ERK and protein kinase A in virus multiplication","volume":"276","author":"de Magalh\u00e3es","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.09.004_b0050","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1128\/JCM.43.2.696-702.2005","article-title":"Duplex reverse transcription-PCR followed by nested PCR assays for detection and identification of Brazilian alphaviruses and flaviviruses","volume":"43","author":"De Morais Bronzoni","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2014.09.004_b0055","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.antiviral.2011.08.002","article-title":"Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo","volume":"92","author":"Droebner","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.09.004_b0060","doi-asserted-by":"crossref","first-page":"18623","DOI":"10.1074\/jbc.273.29.18623","article-title":"Identification of a novel inhibitor of mitogen-activated protein kinase kinase","volume":"273","author":"Favata","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.09.004_b0065","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.chom.2009.04.001","article-title":"Pathogenesis of flavivirus infections: using and abusing the host cell","volume":"5","author":"Fernandez-Garcia","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2014.09.004_b0070","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.micinf.2010.03.007","article-title":"Dengue virus 3 clinical isolates show different patterns of virulence in experimental mice infection","volume":"12","author":"Ferreira","year":"2010","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2014.09.004_b0075","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3201\/eid1402.070278","article-title":"Dengue virus 3 genotype 1 associated with dengue fever and dengue hemorrhagic fever, Brazil","volume":"14","author":"Figueiredo","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.09.004_b0080","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.09.004_b0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cll.2010.01.001","article-title":"Yellow fever: a reemerging threat","volume":"30","author":"Gardner","year":"2010","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.antiviral.2014.09.004_b0090","doi-asserted-by":"crossref","first-page":"10438","DOI":"10.1128\/JVI.00986-10","article-title":"The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex","volume":"84","author":"Gillespie","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.09.004_b0095","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1574-695X.2011.00792.x","article-title":"Transcriptional regulation and activation of the mitogen-activated protein kinase pathway after Japanese encephalitis virus infection in neuroblastoma cells","volume":"62","author":"Gupta","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.antiviral.2014.09.004_b0100","series-title":"Fields Virology","first-page":"712","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2013"},{"key":"10.1016\/j.antiviral.2014.09.004_b0105","doi-asserted-by":"crossref","first-page":"10787","DOI":"10.1128\/JVI.75.22.10787-10799.2001","article-title":"Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively","volume":"75","author":"Mackenzie","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.09.004_b0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2014.09.004_b0115","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/jac\/dks147","article-title":"Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug","volume":"67","author":"Mastrangelo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2014.09.004_b0120","doi-asserted-by":"crossref","first-page":"11329","DOI":"10.1074\/jbc.M410161200","article-title":"Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells","volume":"280","author":"Mazzocca","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.09.004_b0125","doi-asserted-by":"crossref","first-page":"e1002829","DOI":"10.1371\/journal.ppat.1002829","article-title":"MAP-kinase regulated cytosolic phospholipase A2 activity is essential for production of infectious hepatitis C virus particles","volume":"8","author":"Menzel","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.09.004_b0130","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1074\/jbc.M609919200","article-title":"The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner","volume":"282","author":"Miller","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.09.004_b0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1743-422X-10-205","article-title":"The eukaryotic translation initiation factor 3 subunit L protein interacts with Flavivirus NS5 and may modulate yellow fever virus replication","volume":"10","author":"Morais","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2014.09.004_b0140","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1089\/089771502320914642","article-title":"Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury","volume":"19","author":"Mori","year":"2002","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.antiviral.2014.09.004_b0145","doi-asserted-by":"crossref","first-page":"11569","DOI":"10.1073\/pnas.181213498","article-title":"Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia","volume":"98","author":"Namura","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.09.004_b0150","doi-asserted-by":"crossref","first-page":"12591","DOI":"10.1128\/JVI.78.22.12591-12602.2004","article-title":"The transmembrane domains of the prM and E proteins of yellow fever virus are endoplasmic reticulum localization signals","volume":"78","author":"Op De Beeck","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.09.004_b0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.antiviral.2010.04.014","article-title":"Role of host cell factors in flavivirus infection: implications for pathogenesis and development of antiviral drugs","volume":"87","author":"Pastorino","year":"2010","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.09.004_b0160","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1128\/JVI.05638-11","article-title":"A vaccinia virus-driven interplay between the MKK4\/7-JNK1\/2 pathway and cytoskeleton reorganization","volume":"86","author":"Pereira","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.09.004_b0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.coviro.2012.12.001","article-title":"Flaviviruses: braking the entering","volume":"3","author":"Pierson","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2014.09.004_b0170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2011.05.009","article-title":"Inhibition of influenza virus-induced NF-kappaB and Raf\/MEK\/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivo","volume":"92","author":"Pinto","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.09.004_b0175","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.antiviral.2013.04.008","article-title":"Development of cellular signaling pathway inhibitors as new antivirals against influenza","volume":"98","author":"Planz","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.09.004_b0180","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1038\/sj.onc.1210392","article-title":"Differential regulation and properties of MAPKs","volume":"26","author":"Raman","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.antiviral.2014.09.004_b0185","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.4023707","article-title":"Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution","volume":"229","author":"Rice","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.09.004_b0190","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1091\/mbc.E05-07-0662","article-title":"Extracellular signal-regulated kinase regulates clathrin-independent endosomal trafficking","volume":"17","author":"Robertson","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.antiviral.2014.09.004_b0195","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1128\/JVI.80.9.4623-4632.2006","article-title":"Regulated cleavages at the West Nile virus NS4A-2K-NS4B junctions play a major role in rearranging cytoplasmic membranes and Golgi trafficking of the NS4A protein","volume":"80","author":"Roosendaal","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.09.004_b0200","doi-asserted-by":"crossref","first-page":"8721","DOI":"10.1128\/JVI.00144-10","article-title":"Virus-induced Ca2+ influx extends survival of west nile virus-infected cells","volume":"84","author":"Scherbik","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.09.004_b0205","doi-asserted-by":"crossref","unstructured":"Smith, J.L., Stein, D.A., Shum, D., et al., 2014. Inhibition of dengue virus replication by a class of small molecule compounds that antagonize dopamine receptor 4 and downstream mitogen activated protein kinase signaling. J. Virol. (in press).","DOI":"10.1128\/JVI.00365-14"},{"key":"10.1016\/j.antiviral.2014.09.004_b0210","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1128\/JVI.00245-09","article-title":"Activation of the PI3K\/Akt pathway early during vaccinia and cowpox virus infection is required for both host survival and viral replication","volume":"83","author":"Soares","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.09.004_b0215","doi-asserted-by":"crossref","first-page":"8730","DOI":"10.1128\/JVI.00384-12","article-title":"Identification of a novel antiviral inhibitor of the flavivirus guanylyltransferase enzyme","volume":"86","author":"Stahla-Beek","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.09.004_b0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2014.09.004_b0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.brainres.2003.09.074","article-title":"Inhibition of MEK\/ERK 1\/2 pathway reduces pro-inflammatory cytokine interleukin-1 expression in focal cerebral ischemia","volume":"996","author":"Wang","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.antiviral.2014.09.004_b0230","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chom.2009.03.007","article-title":"Composition and three-dimensional architecture of the dengue virus replication and assembly sites","volume":"5","author":"Welsch","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2014.09.004_b0235","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.micinf.2010.04.007","article-title":"Japanese encephalitis virus down-regulates thioredoxin and induces ROS-mediated ASK1-ERK\/p38 MAPK activation in human promonocyte cells","volume":"12","author":"Yang","year":"2010","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2014.09.004_b0240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yexcr.2004.12.024","article-title":"Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK\/ERK signaling pathway via cellular receptors","volume":"305","author":"Zhao","year":"2005","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.antiviral.2014.09.004_b0245","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12192-013-0405-3","article-title":"ERK signaling is triggered by hepatitis C virus E2 protein through DC-SIGN","volume":"18","author":"Zhao","year":"2013","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.antiviral.2014.09.004_b0250","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1189\/jlb.0106014","article-title":"Up-regulation of ERK and p38 MAPK signaling pathways by hepatitis C virus E2 envelope protein in human T lymphoma cell line","volume":"80","author":"Zhao","year":"2006","journal-title":"J. Leukoc. Biol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214002575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T15:59:33Z","timestamp":1538236773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214002575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":49,"alternative-id":["S0166354214002575"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.09.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MEK\/ERK activation plays a decisive role in yellow fever virus replication: Implication as an antiviral therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}